OGL MEDICAL
0898.012.538 · rovalta.com · 26/09/2026
NORMAL SITUATION
OGL MEDICAL
Company — Normal situation.
Financial year 2024 · Closed on 31/12/2024
Net result4,3 k €-34,7 %over 1 year
Gross margin17,2 k €-9,6 %over 1 year
Equity28 k €+18,2 %over 1 year
Overview
Identity
Source · BCE/KBOOGL MEDICAL is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0898.012.538
- Legal form
- Private limited company
- Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2024
Signals
ProfitablePositive cashflowPositive EBITDA
Financials
Source · NBB, 16 filingsTrend over 16 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 17,2 k € | -9.6% | 19 k € | -21.1% | 24,1 k € | +3.0% | 23,4 k € | +0.8% | 23,2 k € |
| EBITDA | 16,2 k € | -8.4% | 17,7 k € | -23.9% | 23,3 k € | +3.1% | 22,6 k € | +0.8% | 22,4 k € |
| Operating result | 9,1 k € | -17.5% | 11 k € | -32.7% | 16,3 k € | +4.4% | 15,6 k € | -6.0% | 16,6 k € |
| Net result | 4,3 k € | -34.7% | 6,6 k € | -48.7% | 12,9 k € | +8.6% | 11,9 k € | -5.3% | 12,5 k € |
| Balance sheet | |||||||||
| Equity | 28 k € | +18.2% | 23,7 k € | +38.8% | 17,1 k € | +309% | 4,2 k € | +154% | -7,7 k € |
| Total assets | 115,4 k € | -4.2% | 120,4 k € | -2.1% | 123 k € | -6.2% | 131,1 k € | -0.9% | 132,3 k € |
| Cash | 8 k € | +55.2% | 5,1 k € | -13.4% | 5,9 k € | -17.0% | 7,1 k € | +388% | 1,5 k € |
| Debts | 87,4 k € | -9.7% | 96,8 k € | -8.6% | 105,9 k € | -16.5% | 126,9 k € | -9.4% | 140 k € |
Board of directors
Source · NBB, accounts to 31/12/20241 active · 2 ended
Active mandates
GUYVE LAMRASKI
ActiveEnded mandates
Guyve Lamraski
EndedGuyve LAMRASKI
EndedFinancials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 10/04/2025 | 15/04/2024 | 27/05/2023 | 01/06/2022 | 04/06/2021 | 24/06/2020 |
| General meeting | 18/03/2025 | 26/03/2024 | 25/05/2023 | 25/05/2022 | 25/05/2021 | 25/05/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 16 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2024 | 18/03/2025 | 10/04/2025 | Dutch | |
| Micro model | 31/12/2023 | 26/03/2024 | 15/04/2024 | Dutch | |
| Micro model | 31/12/2022 | 25/05/2023 | 27/05/2023 | French | |
| Micro model | 31/12/2021 | 25/05/2022 | 01/06/2022 | French | |
| Micro model | 31/12/2020 | 25/05/2021 | 04/06/2021 | French | |
| Micro model | 31/12/2019 | 25/05/2020 | 24/06/2020 | French | |
| Micro model | 31/12/2018 | 25/05/2019 | 11/06/2019 | French | |
| Micro model | 31/12/2017 | 17/05/2018 | 22/05/2018 | French | |
| Micro model | 31/12/2016 | 08/05/2017 | 19/05/2017 | French | |
| Abridged model | 31/12/2015 | 25/05/2016 | 16/08/2016 | French | |
| Abridged model | 31/12/2014 | 26/05/2015 | 27/05/2015 | French | |
| Abridged model | 31/12/2013 | 26/05/2014 | 14/07/2014 | French | |
| Abridged model | 31/12/2012 | 25/05/2013 | 22/06/2013 | French | |
| Abridged model | 31/12/2011 | 16/06/2012 | 21/06/2012 | French | |
| Abridged model | 31/12/2010 | 07/09/2011 | 17/09/2011 | Dutch | |
| Abridged model | 31/12/2009 | 29/06/2010 | 18/08/2010 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active · 2 ended
Active mandates
GUYVE LAMRASKI
ActiveEnded mandates
Guyve Lamraski
EndedGuyve LAMRASKI
EndedOwnership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution31/10/2025RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ...
- Mandates05/01/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DOEL - ONTSLAGEN - BENOEMINGEN
- Registered office03/12/2014SIEGE SOCIAL
- Other08/12/2011DOEL - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Registered office20/05/2010MAATSCHAPPELIJKE ZETEL
- Other29/05/2008RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 20244,3 k €↓
- 2023Annual accounts 20236,6 k €↓
- 2022Annual accounts 202212,9 k €↑
- 2021Annual accounts 202111,9 k €↓
- 2020Annual accounts 202012,5 k €↓
- 2019Annual accounts 201913,1 k €↑
- 2018Annual accounts 20186,2 k €↓
- 2017Annual accounts 20177,9 k €↑
- 2016Annual accounts 2016-68,1 k €↓
- 2015Annual accounts 201520,4 k €↑
- 2014Annual accounts 20142,5 k €↑
- 2013Annual accounts 2013-9,6 k €↓
- 2012Annual accounts 201227,5 k €↑
- 2011Annual accounts 201110 k €↑
- 2010Annual accounts 20109 k €↓
- 2009Annual accounts 2009100 k €